Monitoring Agency Report

Date: 06th November 2026 BSE Limited, National Stock Exchange of India Limited, 20th Floor, P.J. Towers, Dalal Street, Exchange Plaza, C-1, Block G, Bandra Kurla Complex, Mumbai – 400001, Maharashtra, India Bandra (E), Mumbai – 400 051, Maharashtra, India BSE Scrip Code: 544888 NSE Scrip Symbol: AUGMONT Subject: Submission of Monitoring Agency Report under Regulation 32(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015, for the quarter ended 30th September 2026: Dear Sir(s) / Madam(s), Pursuant to Regulation 32(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”) read with Regulation 41(4) of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018 (“ICDR Regulations”), please find enclosed herewith the Monitoring Agency Report for the quarter ended 30th September, 2026, issued by CARE Ratings Limited (“Monitoring Agency”), in respect of the utilization of issue proceeds, raised through the public issue of the Company. The draft Monitoring Agency Report has been reviewed and approved by the Audit Committee and taken on record by the Board of Directors at their respective meetings held on 04th November 2026. This intimation / disclosure is being submitted for your information and records. You are requested to kindly take the same on record and disseminate it appropriately to all concerned. For Augmont Enterprises Limited (formerly known as Augmont Enterprises Private Limited) Sunny Parekh Company Secretary and Compliance Officer Membership No.: ACS32611 No. CARE/ARO/GEN/2026-27/1217 The Board of Directors Augmont Enterprises Limited 201/A, 201/B and 203, 2nd floor, Trade World, D Wing, Kamal Mills Compound, S.B. Marg, Lower Parel West, Mumbai, Maharashtra - 400013 November 05, 2026 Dear Sir/Ma’am, Monitoring Agency Report for the quarter ended September 30, 2026 - in relation to the IPO of Augmont Enterprises Limited (“the Company”) We write in our capacity of Monitoring Agency for the Initial Public Offering (IPO) for the amount aggregating to Rs.620 crore of the Company and refer to our duties cast under regulation 41 of the Securities & Exchange Board of India (Issue of Capital & Disclosure Requirements) Regulations, 2018. In this connection, we are enclosing the Monitoring Agency Report for the quarter ended September 30, 2026, as per aforesaid SEBI Regulations and Monitoring Agency Agreement dated August 05, 2026. Request you to kindly take the same on records. Thanking you, Yours faithfully, Anuja Parikh Associate Director anuja.parikh@careedge.in Report of the Monitoring Agency Name of the issuer: Augmont Enterprises Limited For quarter ended: September 30, 2026 Name of the Monitoring Agency: CARE Ratings Limited (a) Deviation from the objects: Nil (b) Range of Deviation: Not Applicable Declaration: We declare that this report provides an objective view of the utilization of the issue proceeds in relation to the objects of the issue based on the information provided by the Issuer and information obtained from sources believed by it to be accurate and reliable. The MA does not perform an audit and undertakes no independent verification of any information/ certifications/ statements it receives. This Report is not intended to create any legally binding obligations on the MA which accepts no responsibility, whatsoever, for loss or damage from the use of the said information. The views and opinions expressed herein do not constitute the opinion of MA to deal in any security of the Issuer in any manner whatsoever. Nothing mentioned in this report is intended to or should be construed as creating a fiduciary relationship between the MA and any issuer or between the agency and any user of this report. The MA and its affiliates also do not act as an expert as defined under Section 2(38) of the Companies Act, 2013. The MA or its affiliates may have credit rating or other commercial transactions with the entity to which the report pertains and may receive separate compensation for its ratings and certain credit related analyses. We confirm that there is no conflict of interest in such relationship/interest while monitoring and reporting the utilization of the issue proceeds by the issuer, or while undertaking credit rating or other commercial transactions with the entity. We have submitted the report herewith in line with the format prescribed by SEBI, capturing our comments, where applicable. There are certain sections of the report under the title “Comments of the Board of Directors”, that shall be captured by the Issuer’s Management / Audit Committee of the Board of Directors subsequent to the MA submitting their report to the issuer and before dissemination of the report through stock exchanges. These sections have not been reviewed by the MA, and the MA takes no responsibility for such comments of the issuer’s Management/Board. Signature: Name and designation of the Authorized Signatory: Anuja Parikh Designation of Authorized person/Signing Authority: Associate Director 1) Issuer Details: Name of the issuer : Augmont Enterprises Limited Name of the promoter : Ketan Bhawarlal Kothari, Vivek Prithviraj Kothari, Mohinidevi Bhawarlal Kothari, Kalawati Prithviraj Kothari, Namita Ketan Kothari, Devkumari Manekchand Kothari, Manakchand Saremal Kothari, Dimple Mukesh Kothari, Dimpal Vivek Kothari Industry/sector to which it belongs : Precious Metals & Jewellery 2) Issue Details Issue Period : August 21, 2026 to August 25, 2026 Type of issue (public/rights) : Initial Public Offering Type of specified securities : Equity shares IPO Grading, if any : Not applicable Issue size (in crore) : Rs.620.00 crore of fresh issue 3) Details of the arrangement made to ensure the monitoring of issue proceeds: Source of information / certifications Comments of the Comments of the Particulars Reply considered by Monitoring Agency for Board of Monitoring Agency preparation of report Directors The company has utilized Rs. 465.23 crore towards one of the objectives – Whether all utilization is as per the disclosures in the Offer Chartered Accountant certificate*; Yes working capital purposes, marginally Noted the same. Document? Bank statement, Company Declaration higher than the cost of objective of Rs.465 crore. Whether shareholder approval has been obtained in case of Not Chartered Accountant certificate*; No shareholder approval required material deviations# from expenditures disclosed in the Offer Noted the same. applicable Company Declaration since there is no material deviation Document? Whether the means of finance for the disclosed objects of the No Company declaration No comments No comments issue have changed? Is there any major deviation observed over the earlier monitoring Not Not applicable as this is first monitoring Not applicable No comments agency reports? applicable agency report Whether all Government/statutory approvals related to the Not Company declaration No comments No comments object(s) have been obtained? applicable Whether all arrangements pertaining to technical Not Company declaration No comments No comments assistance/collaboration are in operation? applicable Source of information / certifications Comments of the Comments of the Particulars Reply considered by Monitoring Agency for Board of Monitoring Agency preparation of report Directors Are there any favorable/unfavorable events affecting the viability Company declaration No No comments No comments of these object(s)? Stock exchange filings Is there any other relevant information that may materially affect Company declaration No No comments No comments the decision making of the investors? Stock exchange filings * Chartered Accountant certificate from M/s. K. K. Mankeshwar & Co. dated October 28, 2026 #Where material deviation may be defined to mean: a) Deviation in the objects or purposes for which the funds have been raised b) Deviation in the amount [Showing first 8,000 characters — download PDF for full document]